Compare REAL & AZTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | REAL | AZTA |
|---|---|---|
| Founded | 2011 | 1978 |
| Country | United States | United States |
| Employees | N/A | 3000 |
| Industry | Other Specialty Stores | Industrial Machinery/Components |
| Sector | Consumer Discretionary | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.8B |
| IPO Year | 2019 | 1995 |
| Metric | REAL | AZTA |
|---|---|---|
| Price | $14.58 | $38.78 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 5 |
| Target Price | $16.57 | ★ $43.20 |
| AVG Volume (30 Days) | ★ 2.6M | 581.9K |
| Earning Date | 02-26-2026 | 02-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $662,789,000.00 | $593,821,000.00 |
| Revenue This Year | $17.10 | $6.18 |
| Revenue Next Year | $10.90 | $5.24 |
| P/E Ratio | ★ N/A | $73.36 |
| Revenue Growth | ★ 14.30 | 3.55 |
| 52 Week Low | $4.61 | $23.91 |
| 52 Week High | $17.39 | $55.64 |
| Indicator | REAL | AZTA |
|---|---|---|
| Relative Strength Index (RSI) | 39.81 | 56.18 |
| Support Level | $15.14 | $37.21 |
| Resistance Level | $16.50 | $41.73 |
| Average True Range (ATR) | 0.88 | 1.31 |
| MACD | -0.25 | -0.19 |
| Stochastic Oscillator | 1.75 | 38.44 |
The RealReal is the largest pure-play luxury resale platform in the US, generating $1.8 billion in 2024 gross merchandise volume and addressing a niche (personal luxury resale) that had previously been serviced by inefficient upscale boutiques and local pawn shops. The company generates revenue via consignment and first-party sales on its online marketplace, and through a small volume of direct sales. With a hands-on approach that actively sources inventory and authenticates every item on its platform, The RealReal is able to justify much higher take rates than peers, working out to roughly 36% of net merchandise value in 2024, which excludes returns, cancellations, and first-party sales.
Azenta Inc provides biological and chemical sample exploration and management solutions, using precision automation and cryogenics to develop automated ultra-cold storage. It serves customers from research to commercialization with sample management, automated storage, genomic services, consumables, informatics, and repository services. The company operates through two segments: Sample Management Solutions, offering SRS and Core Products such as automated stores, cryogenic systems, sample tubes, consumables, instruments, and thawing devices, which generate majority of its revenue; and Multiomics, which provides genomic analysis services. The company operates in United States, China, United Kingdom, rest of Europe, and others, with majority of its revenue in the United States.